Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $519.04 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $152.02 | 2 | $0 (2022) |
| Allergan Inc. | $133.08 | 7 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $84.94 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $55.55 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $28.91 | 2 | $0 (2018) |
| Organon LLC | $24.99 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.13 | 1 | $0 (2018) |
| Amgen Inc. | $12.75 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $12.67 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.94 | 1 | Teva Pharmaceuticals USA, Inc. ($84.94) |
| 2022 | $177.01 | 3 | Abbott Laboratories ($152.02) |
| 2019 | $56.04 | 4 | Allergan Inc. ($16.18) |
| 2018 | $77.01 | 5 | E.R. Squibb & Sons, L.L.C. ($27.97) |
| 2017 | $124.04 | 7 | Allergan Inc. ($95.90) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $84.94 | General |
| Category: Central Nervous System | ||||||
| 07/25/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ETONOGESTREL | ||||||
| 05/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $116.30 | General |
| Category: Diabetes Care | ||||||
| 05/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: Diabetes Care | ||||||
| 11/13/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: WOMENS HEALTH | ||||||
| 03/01/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 01/11/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Bone Health | ||||||
| 12/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Cardiovascular | ||||||
| 10/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Cardiovascular | ||||||
| 02/15/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Cardiovascular | ||||||
| 02/08/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 654 | 767 | $165,389 | $64,293 |
| 2022 | 6 | 584 | 742 | $151,361 | $25,070 |
| 2021 | 7 | 655 | 843 | $176,636 | $72,853 |
| 2020 | 6 | 633 | 796 | $164,337 | $57,425 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 171 | 171 | $45,067 | $21,792 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 293 | $54,701 | $18,000 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 55 | 55 | $14,495 | $7,009 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 69 | 76 | $14,938 | $5,103 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 59 | $15,406 | $5,066 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 27 | $7,790 | $2,919 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 53 | $6,725 | $2,164 | 32.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,432 | $1,206 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 21 | $2,835 | $1,035 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 392 | $69,630 | $15,705 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 63 | $14,996 | $2,801 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 64 | $7,721 | $2,687 | 34.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,324 | $1,602 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 196 | 196 | $51,656 | $1,374 | 2.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $4,034 | $901.51 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 222 | 222 | $58,508 | $29,646 | 50.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 253 | 418 | $74,266 | $25,924 | 34.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 78 | 87 | $20,860 | $8,583 | 41.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 23 | 27 | $7,313 | $3,133 | 42.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 54 | $6,653 | $2,182 | 32.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 13 | 13 | $3,601 | $1,763 | 49.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2021 | 16 | 22 | $5,436 | $1,622 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 224 | 224 | $59,035 | $26,371 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 250 | 395 | $70,220 | $19,794 | 28.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 58 | 67 | $16,099 | $5,071 | 31.5% |
About Dr. Katy Wessel, D.O
Dr. Katy Wessel, D.O is a General Practice healthcare provider based in Helena, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437368487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katy Wessel, D.O has received a total of $519.04 in payments from pharmaceutical and medical device companies, with $84.94 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($519.04).
As a Medicare-enrolled provider, Wessel has provided services to 2,526 Medicare beneficiaries, totaling 3,148 services with total Medicare billing of $219,642. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Helena, MT
- Active Since 05/22/2007
- Last Updated 03/28/2018
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437368487
Products in Payments
- FREESTYLE LIBRE (Device) $152.02
- Austedo XR (Drug) $84.94
- LINZESS (Drug) $73.38
- ELIQUIS (Drug) $55.55
- VIBERZI (Drug) $43.52
- NEXPLANON (Drug) $37.66
- VRAYLAR (Drug) $16.18
- BREO (Drug) $15.00
- STIOLTO RESPIMAT (Drug) $14.13
- ADVAIR (Drug) $13.91
- Prolia (Biological) $12.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Helena
Dr. Christopher Mast, D.d.s, D.D.S
General Practice — Payments: $36,750
Dr. Aaron Cross, D.o, D.O
General Practice — Payments: $5,360
Dr. Brandon Kiesling, D.m.d, D.M.D
General Practice — Payments: $3,759
Dr. Bradley Grammens, Dds, DDS
General Practice — Payments: $3,735
Dr. Paul Maes, Dds Magd, DDS MAGD
General Practice — Payments: $3,701
Michael Welch, Dds, DDS
General Practice — Payments: $3,328